Cognition Therapeutics to Present at the Needham Virtual Healthcare ConferenceGlobe Newswire • 24 days ago
PURCHASE, N.Y., April 02, 2024 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (the Company or Cognition ) (NASDAQ: CGTX), a clinical stage company developing drugs that treat neurodegenerative...
Share to Feed
NEW YORK, April 01, 2024 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (the Company or Cognition ) (NASDAQ: CGTX), a clinical stage company developing drugs that treat neurodegenerative...
Cognition Therapeutics (NASDAQ:CGTX - Get Free Report)s stock had its "buy" rating restated by investment analysts at B. Riley in a research note issued on Thursday, Benzinga reports. They...
Related Stocks: NAS:CGTX...
- Topline Results from SHINE Study in Mild-to-Moderate Alzheimer's Expected mid-2024 -- On Track to Report Topline Results from SHIMMER Study in Mild-to-Moderate DLB in 2H 2024 - - 1Q 2024 Capital...
Cognition Therapeutics reports FY results...
Conference Call and Live Audio Webcast Scheduled for March 26, 2024PURCHASE, N.Y., March 15, 2024 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (Nasdaq: CGTX), a clinical-stage neuroscience...
The Dow Jones index closed lower by more than 100 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and...
PURCHASE, N.Y., March 14, 2024 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. ( Cognition, the Company or We ) (Nasdaq: CGTX), a clinical stage company developing product candidates designed...